Literature DB >> 25133058

A case report of the use of vilazodone in pregnancy.

Caroline M Morrison1.   

Abstract

Entities:  

Year:  2014        PMID： 25133058      PMCID： PMC4116287          DOI： 10.4088/PCC.13l01612

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  6 in total

1.  Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study.

Authors:  L S Cohen; R M Nonacs; J W Bailey; A C Viguera; A M Reminick; L L Altshuler; Z N Stowe; S V Faraone
Journal:  Arch Womens Ment Health       Date:  2004-08-30       Impact factor: 3.633

Review 2.  The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-09       Impact factor: 7.661

Review 3.  Complex challenges in treating depression during pregnancy.

Authors:  Linda H Chaudron
Journal:  Am J Psychiatry       Date:  2013-01       Impact factor: 18.112

4.  A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy.

Authors:  Adrienne Einarson; Lori Bonari; Sharon Voyer-Lavigne; Antonio Addis; Doreen Matsui; Yvette Johnson; Gideon Koren
Journal:  Can J Psychiatry       Date:  2003-03       Impact factor: 4.356

5.  Does fetal exposure to SSRIs or maternal depression impact infant growth?

Authors:  Katherine L Wisner; Debra L Bogen; Dorothy Sit; Mary McShea; Carolyn Hughes; David Rizzo; Andrea Confer; James Luther; Heather Eng; Stephen W Wisniewski
Journal:  Am J Psychiatry       Date:  2013-05       Impact factor: 18.112

6.  Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.

Authors:  Olof Stephansson; Helle Kieler; Bengt Haglund; Miia Artama; Anders Engeland; Kari Furu; Mika Gissler; Mette Nørgaard; Rikke Beck Nielsen; Helga Zoega; Unnur Valdimarsdóttir
Journal:  JAMA       Date:  2013-01-02       Impact factor: 56.272
  6 in total
  1 in total

Review 1.  Vilazodone for the treatment of major depressive disorder: an evidence-based review of its place in therapy.

Authors:  David J Hellerstein; Joseph Flaxer
Journal:  Core Evid       Date:  2015-04-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.